Population Pharmacokinetics and Exposure-Response Analyses of Subcutaneous and Intravenous Anifrolumab in Patients With Systemic Lupus Erythematosus (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2219; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • PK/PD data • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
|